Biotech M&A – 2023 Deals

Biotech M&A – 2023 Deals

Biotech M&A With a Quick Start in 2023!

Is There Any Chance to Beat 2022 Numbers ?

DateAcquirer Co.Acquirer TickerAcquired Co.Acquired TickerDeal valuePrice/ShareNotesLink to the news PR
01/04/2023ModernaMRNAOriCiro GenomicsPrivate- Japan$85M-Cynthetic biology and enzyme technologieshttps://bit.ly/3IinwVP
01/09/2023Chiesi Farmaceutici PrivateAmryt PharmaAMYT$1.25B$14.50$2.5 CVR total $225Mhttps://bit.ly/3k62nnS
01/09/2023IPSEN - France IPSEYAlbireoALBO$952$42.00$10 CVRhttps://bwnews.pr/3QmQrtX
01/09/2023Astra AZNCinCor PharmaCINC$1.3B$26.00$10 CVRhttps://bit.ly/3incbsT
01/17/2023Shockwave MedicalSWAVNeovascNVCN$100M$27.25minimally invasive treatment of refractory angina.https://bit.ly/3H8luXc
01/19/2023Sun PharmaIndian Co.Concert PharmaceuticalsCNCE$576M$8.00$3.5 CVR
Oral JAK Inhibitor for the Treatment of Alopecia Areata
https://bwnews.pr/3CZVmvr

For M&A 2022 full table click here https://www.chimeraresearchgroup.com/biotech-ma-2022-deals/

Recent Press

Slider

Log In

JoinLost Password?